Literature DB >> 21507565

A validation study of the Chinese wearing off questionnaire 9-symptom for Parkinson's disease.

A Chan1, Y F Cheung, M Au Yeung, J Yeung, T H Chung, K L Tsang, J Chan, C Lau, P Kwan, Sheng-Han Kuo, V Mok.   

Abstract

OBJECTIVE: Development of wearing off (WO) often goes unnoticed for both patients with Parkinson's disease (PD) and physicians due to the complexity of this phenomenon. A brief 9-symptom WO questionnaire (WOQ-9) was recently found to be highly sensitive in its detection. We aimed to validate a Chinese version WOQ-9 (CWOQ-9) among Chinese patients with PD.
METHODS: We recruited 101 literate Chinese PD patients among 4 different neurology or movement disorders clinics in Hong Kong to participate in this study by completing the CWOQ-9. Clinical judgment by the specialists was considered the gold standard for diagnosing WO.
RESULTS: The mean age (±SD) of the patients was 61 (±9) years and 35 (34.7%) of them were female. The disease duration was 7.4 (±5.4) years and 69 (68.3%) of them were diagnosed clinically to have WO by the specialists. The positive and negative predictive values, sensitivity and specificity of CWOQ-9 were 86%, 71%, 87%, and 69% respectively. The area under curve (AUC) was 0.78 (p<0.001).
CONCLUSION: This simple patient questionnaire is a valid tool for the detection of WO among Chinese PD patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507565      PMCID: PMC6089253          DOI: 10.1016/j.clineuro.2011.03.007

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

Authors:  Mark Stacy; Annette Bowron; Mark Guttman; Robert Hauser; Kim Hughes; Jan Petter Larsen; Peter LeWitt; Wolfgang Oertel; Niall Quinn; Kapil Sethi; Fabrizio Stocchi
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

2.  End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.

Authors:  Mark Stacy; Robert Hauser; Wolfgang Oertel; Anthony Schapira; Kapil Sethi; Fabrizio Stocchi; Eduardo Tolosa
Journal:  Clin Neuropharmacol       Date:  2006 Nov-Dec       Impact factor: 1.592

3.  Nonmotor fluctuations in Parkinson's disease: frequent and disabling.

Authors:  Tatiana Witjas; E Kaphan; J P Azulay; O Blin; M Ceccaldi; J Pouget; M Poncet; A Ali Chérif
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

4.  The sensitivity and specificity of the 9-item Wearing-off Questionnaire.

Authors:  M A Stacy; J M Murphy; D R Greeley; R M Stewart; H Murck; X Meng
Journal:  Parkinsonism Relat Disord       Date:  2007-09-27       Impact factor: 4.891

5.  Validation of the "QUICK" questionnaire--a tool for diagnosis of "wearing-off" in patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Eduardo Tolosa; Basilio Hernandez; Xavier Badia
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

  5 in total
  3 in total

1.  Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease.

Authors:  Huimin Chen; Jinping Fang; Fangfei Li; Liyan Gao; Tao Feng
Journal:  Neurol Sci       Date:  2015-01-24       Impact factor: 3.307

2.  Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China.

Authors:  Wei Chen; Qin Xiao; Ming Shao; Tao Feng; Wei-Guo Liu; Xiao-Guang Luo; Xiao-Chun Chen; An-Mu Xie; Chun-Feng Liu; Zhen-Guo Liu; Yi-Ming Liu; Jian Wang; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2014-12-05       Impact factor: 8.014

Review 3.  Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.

Authors:  Carlos E Mantese; Artur Schumacher-Schuh; Carlos R M Rieder
Journal:  Parkinsons Dis       Date:  2018-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.